Earlier in July 2025, the eWHORM consortium met at the Swiss Tropical and Public Health Institute for in Switzerland for their second general assembly. More than 30 participants representing the partners from Gabon, Germany, Cameroon, Switzerland, Austria and DRC were thrilled to have the opportunity to meet and discuss the progress of the project. 2025 is namely a great milestone for eWHORM, as the ethics and regulatory approvals necessary for the clinical trials were all requested and accepted for the clinical trial countries. Now the phase 2 study with Oxfendazole as anthelminthic for treatment of onchocerciasis, mansonellosis and loaisis can commence. The Swiss TPH already performed the trichuris study on Pemba Island in Tanzania

15.07.2025

eWHORM Partners meet in Basel, Switzerland for their second Progress Meeting

Basel, Switzerland, 15.07.2025

Earlier in July 2025, the eWHORM consortium met at the Swiss Tropical and Public Health Institute for in Switzerland for their second general assembly.

More than 30 participants representing the partners from Gabon, Germany, Cameroon, Switzerland, Austria and DRC were thrilled to have the opportunity to meet and discuss the progress of the project.

2025 is namely a great milestone for eWHORM, as the ethics and regulatory approvals necessary for the clinical trials were all requested and accepted for the clinical trial countries. Now the phase 2 study with Oxfendazole as anthelminthic for treatment of onchocerciasis, mansonellosis and loaisis can commence.

The Swiss TPH already performed the trichuris study on Pemba Island in Tanzania